DK0741726T3 - Substituerede 3-aryliden-7-azaoxindolforbindelser og en fremgangsmåde til fremstilling deraf - Google Patents

Substituerede 3-aryliden-7-azaoxindolforbindelser og en fremgangsmåde til fremstilling deraf

Info

Publication number
DK0741726T3
DK0741726T3 DK95937030T DK95937030T DK0741726T3 DK 0741726 T3 DK0741726 T3 DK 0741726T3 DK 95937030 T DK95937030 T DK 95937030T DK 95937030 T DK95937030 T DK 95937030T DK 0741726 T3 DK0741726 T3 DK 0741726T3
Authority
DK
Denmark
Prior art keywords
nch2oh
choh
alkyl
image
pct
Prior art date
Application number
DK95937030T
Other languages
English (en)
Inventor
Franco Buzzetti
Gabriella Maria Brasca
Dario Ballinari
Antonio Longo
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Application granted granted Critical
Publication of DK0741726T3 publication Critical patent/DK0741726T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
DK95937030T 1994-11-28 1995-10-30 Substituerede 3-aryliden-7-azaoxindolforbindelser og en fremgangsmåde til fremstilling deraf DK0741726T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9423997A GB9423997D0 (en) 1994-11-28 1994-11-28 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
PCT/EP1995/004247 WO1996016964A1 (en) 1994-11-28 1995-10-30 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation

Publications (1)

Publication Number Publication Date
DK0741726T3 true DK0741726T3 (da) 2000-04-17

Family

ID=10765093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937030T DK0741726T3 (da) 1994-11-28 1995-10-30 Substituerede 3-aryliden-7-azaoxindolforbindelser og en fremgangsmåde til fremstilling deraf

Country Status (22)

Country Link
US (1) US5719135A (da)
EP (1) EP0741726B1 (da)
JP (1) JPH09508924A (da)
CN (1) CN1139929A (da)
AT (1) ATE186727T1 (da)
AU (1) AU3926295A (da)
CA (1) CA2180730C (da)
DE (1) DE69513383T2 (da)
DK (1) DK0741726T3 (da)
ES (1) ES2140717T3 (da)
FI (1) FI962954A0 (da)
GB (1) GB9423997D0 (da)
GR (1) GR3032535T3 (da)
HU (1) HUT74875A (da)
IL (1) IL116002A0 (da)
MX (1) MX9602838A (da)
NO (1) NO963066L (da)
NZ (1) NZ295668A (da)
PL (1) PL315689A1 (da)
PT (1) PT741726E (da)
WO (1) WO1996016964A1 (da)
ZA (1) ZA959927B (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6906093B2 (en) 1995-06-07 2005-06-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6316635B1 (en) 1995-06-07 2001-11-13 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US6147106A (en) 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
GB9610964D0 (en) * 1996-05-24 1996-07-31 Pharmacia & Upjohn Spa Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
GB9611797D0 (en) * 1996-06-06 1996-08-07 Pharmacia Spa Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
GB9613021D0 (en) * 1996-06-21 1996-08-28 Pharmacia Spa Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
US6486185B1 (en) 1997-05-07 2002-11-26 Sugen, Inc. 3-heteroarylidene-2-indolinone protein kinase inhibitors
US6316429B1 (en) 1997-05-07 2001-11-13 Sugen, Inc. Bicyclic protein kinase inhibitors
US6987113B2 (en) * 1997-06-11 2006-01-17 Sugen, Inc. Tyrosine kinase inhibitors
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
GB9721437D0 (en) * 1997-10-10 1997-12-10 Glaxo Group Ltd Heteroaromatic compounds and their use in medicine
US6531502B1 (en) 1998-01-21 2003-03-11 Sugen, Inc. 3-Methylidenyl-2-indolinone modulators of protein kinase
JP2002507598A (ja) * 1998-03-26 2002-03-12 スージェン・インコーポレーテッド チロシン蛋白質キナーゼを調節するためのヘテロ環式化合物のファミリー
US6514981B1 (en) 1998-04-02 2003-02-04 Sugen, Inc. Methods of modulating tyrosine protein kinase function with indolinone compounds
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
IL139934A0 (en) * 1998-05-29 2002-02-10 Sugen Inc Pyrrole substituted 2-indolinone derivatives and pharmaceutical compositions containing the same
AU772477B2 (en) 1998-08-28 2004-04-29 Scios Inc. Inhibitors of p38-alpha kinase
US6153634A (en) 1998-12-17 2000-11-28 Hoffmann-La Roche Inc. 4,5-azolo-oxindoles
BR9916327A (pt) 1998-12-17 2001-09-18 Hoffmann La Roche Oxindóis de 4-alquenila (e alquinila) como inibidores de cinases dependentes de ciclina, em particular, cdk2
CN1136217C (zh) 1998-12-17 2004-01-28 霍夫曼-拉罗奇有限公司 作为jnk蛋白质激酶抑制剂的4-芳基羟吲哚
WO2000035921A1 (en) 1998-12-17 2000-06-22 F. Hoffmann-La Roche Ag 4,5-pyrazinoxindoles as protein kinase inhibitors
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
US6492398B1 (en) 1999-03-04 2002-12-10 Smithkline Beechman Corporation Thiazoloindolinone compounds
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6689806B1 (en) 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
US6541477B2 (en) 1999-08-27 2003-04-01 Scios, Inc. Inhibitors of p38-a kinase
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
US6313310B1 (en) 1999-12-15 2001-11-06 Hoffmann-La Roche Inc. 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
CA2395520A1 (en) * 1999-12-21 2001-06-28 Sugen, Inc. 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
AR034118A1 (es) 2000-02-15 2004-02-04 Sugen Inc Compuestos de 2-indolinonas sustituidas con pirroles inhibidoras de proteinquinasas; sus composiciones farmaceuticas e intermediarios de sintesis
US6620818B1 (en) 2000-03-01 2003-09-16 Smithkline Beecham Corporation Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
MY128449A (en) 2000-05-24 2007-02-28 Sugen Inc Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
AU2001268154A1 (en) 2000-06-02 2001-12-17 Sugen, Inc. Indolinone derivatives as protein kinase/phosphatase inhibitors
US6335342B1 (en) 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
EP1353693B1 (en) 2001-01-16 2005-03-16 Glaxo Group Limited Pharmaceutical combination containing a 4-quinazolineamine and paclitaxel, carboplatin or vinorelbine for the treatment of cancer
US6504034B2 (en) 2001-01-23 2003-01-07 Hoffmann-La Roche Inc. Naphthostyrils
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
ES2275021T3 (es) * 2001-09-27 2007-06-01 Smithkline Beecham Corporation Derivados de azoxoindol como inhibidores de trk proteina quinasa para el tratamiento de cancer y dolor cronico.
PL1973910T3 (pl) * 2006-01-27 2013-11-29 Shanghai hengrui pharmaceutical co ltd Pirolo[3,2-c]pirydyn-4-onowo-2-indolinonowe inhibitory kinazy białkowej
CN101367801B (zh) * 2007-08-15 2011-01-12 上海恒瑞医药有限公司 吡咯并六元n杂环羟基吗啡啉类衍生物的制备方法及其在医药上的应用
US9493452B2 (en) * 2011-03-24 2016-11-15 Southern Methodist University Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
US8669363B2 (en) 2011-03-24 2014-03-11 Southern Methodist University Quinoxaline compounds and derivatives
WO2013142831A1 (en) 2012-03-23 2013-09-26 Southern Methodist University Methods of making and using thioxothiazolidine and rhodanine derivatives as hiv-1 and jsp-1 inhibitors
CN103864784B (zh) * 2014-02-28 2017-05-03 温州医科大学 一种新型氮杂吲哚‑2‑酮类fgfr1抑制剂及其抗肿瘤活性
WO2022006238A1 (en) * 2020-07-01 2022-01-06 Angion Biomedica Corp. Solid forms of (z)-methyl 3-(((4-(n-methyl-2-(4-methylpiperazin-l- yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxo-2, 3-dihydro- lh-pyrrolo[2,3-b]pyridine-6-carboxylate and salts thereof
WO2022120181A1 (en) 2020-12-03 2022-06-09 Mydecine Innovations Group Inc. Novel psilocin analog compositions and methods of synthesizing the same
CN119998304A (zh) * 2022-09-30 2025-05-13 三菱化学株式会社 化合物、金属络合物、烯烃聚合用催化剂组合物、烯烃聚合用催化剂和烯烃系聚合物的制造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226855D0 (en) * 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation

Also Published As

Publication number Publication date
NZ295668A (en) 1997-11-24
MX9602838A (es) 1997-06-28
HU9602357D0 (en) 1996-11-28
CA2180730A1 (en) 1996-06-06
GB9423997D0 (en) 1995-01-11
CA2180730C (en) 2006-09-12
WO1996016964A1 (en) 1996-06-06
NO963066D0 (no) 1996-07-23
AU3926295A (en) 1996-06-19
EP0741726A1 (en) 1996-11-13
DE69513383T2 (de) 2000-05-18
CN1139929A (zh) 1997-01-08
FI962954A7 (fi) 1996-07-24
ZA959927B (en) 1996-06-10
US5719135A (en) 1998-02-17
PT741726E (pt) 2000-04-28
PL315689A1 (en) 1996-11-25
DE69513383D1 (de) 1999-12-23
HUT74875A (en) 1997-02-28
ATE186727T1 (de) 1999-12-15
ES2140717T3 (es) 2000-03-01
IL116002A0 (en) 1996-01-31
FI962954A0 (fi) 1996-07-24
JPH09508924A (ja) 1997-09-09
EP0741726B1 (en) 1999-11-17
GR3032535T3 (en) 2000-05-31
NO963066L (no) 1996-07-23

Similar Documents

Publication Publication Date Title
NO963066D0 (no) Substituerte 3-aryliden-7-azaoksindolforbindelser og fremgangsmåte for deres fremstilling
DK0715628T3 (da) Substituerede azaindolyliden-forbindelser og fremgangsmåde til fremstilling deraf
DE69512797D1 (en) Prostaglandin-synthase hemmer
NZ511739A (en) New esters derived from substituted phenyl-cyclohexyl compounds
DK116480A (da) Fremgangsmaade til fremstilling af substituerede chromoner
DE3062609D1 (en) Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
ES8308543A1 (es) "procedimiento para la preparacion de nuevas 2-fenil-2-(piridiloxi)-etilaminas sustituidas".
HU9402466D0 (en) Indole derivatives as steroid-5-alpha-reductase inhibitors
NO166321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinforbindelser.
DE3269505D1 (en) Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them
HU894471D0 (en) Process for the preparation of 15-amino-20,21-dinor-eburnamenine derivatives and pharmaceutical compositions containing them
PT77728A (en) Process for preparing acridanone derivatives and of pharmaceutical compositions containing the same
GB2001627A (en) alpha -Vinyl and ethynyl amino acid derivatives
FI931580L (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi